95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.93%
Negative revenue growth while FSM stands at 13.30%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-17.34%
Negative gross profit growth while FSM is at 12.65%. Joel Greenblatt would examine cost competitiveness or demand decline.
-16.55%
Negative EBIT growth while FSM is at 46.03%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-16.55%
Negative operating income growth while FSM is at 46.03%. Joel Greenblatt would press for urgent turnaround measures.
-15.36%
Negative net income growth while FSM stands at 108.25%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.00%
Negative EPS growth while FSM is at 100.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.00%
Negative diluted EPS growth while FSM is at 100.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.05%
Share change of 0.05% while FSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.12%
Diluted share count expanding well above FSM's 0.21%. Michael Burry would fear significant dilution to existing owners' stakes.
-44.44%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-25.60%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-394.81%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
474.43%
10Y CAGR of 474.43% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
155.90%
5Y revenue/share CAGR at 75-90% of FSM's 173.34%. Bill Ackman would encourage strategies to match competitor’s pace.
104.72%
3Y revenue/share CAGR at 50-75% of FSM's 146.97%. Martin Whitman would question if the firm lags behind competitor innovations.
318.78%
10Y OCF/share CAGR under 50% of FSM's 759.43%. Michael Burry would worry about a persistent underperformance in cash creation.
198.21%
5Y OCF/share CAGR above 1.5x FSM's 86.67%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
151.07%
3Y OCF/share CAGR under 50% of FSM's 313.02%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2734.24%
Net income/share CAGR above 1.5x FSM's 772.44% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
292.06%
5Y net income/share CAGR 1.25-1.5x FSM's 235.84%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
215.81%
Below 50% of FSM's 1176.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
3071.55%
10Y equity/share CAGR above 1.5x FSM's 994.07%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
146.06%
5Y equity/share CAGR above 1.5x FSM's 51.28%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
59.98%
3Y equity/share CAGR at 75-90% of FSM's 77.85%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.09%
AR growth well above FSM's 12.89%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-0.34%
Negative asset growth while FSM invests at 5.52%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.54%
1.25-1.5x FSM's 3.97%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-11.10%
We’re deleveraging while FSM stands at 852.08%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-8.05%
We cut SG&A while FSM invests at 48.35%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.